Acquisition by Tesi Raymond Joseph of 18028 shares of INmune Bio at 8.32 subject to Rule 16b-3
| INMB Stock | USD 7.29 0.14 1.88% |
About 61% of INmune Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding INmune Bio suggests that many traders are alarmed. The current market sentiment, together with INmune Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use INmune Bio stock news signals to limit their universe of possible portfolio assets.
Filed transaction by INmune Bio Director, 10 Percent Owner, Officer President And Ceo. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
INmune Bio Fundamental Analysis
We analyze INmune Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INmune Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INmune Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
INmune Bio is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
INmune Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with INmune Bio stock to make a market-neutral strategy. Peer analysis of INmune Bio could also be used in its relative valuation, which is a method of valuing INmune Bio by comparing valuation metrics with similar companies.
Peers
INmune Bio Related Equities
| SAVA | Cassava Sciences | 9.04 | ||||
| ANTX | AN2 Therapeutics | 3.36 | ||||
| AVXL | Anavex Life | 2.45 | ||||
| TCRX | Tscan Therapeutics | 2.34 | ||||
| DRMA | Dermata Therapeutics | 1.28 | ||||
| ANIX | Anixa Biosciences | 1.18 | ||||
| PYPD | PolyPid | 1.72 | ||||
| CGTX | Cognition Therapeutics | 3.03 | ||||
| CUE | Cue Biopharma | 4.00 | ||||
| BIVI | Biovie | 4.55 | ||||
| ANEB | Anebulo Pharmaceuticals | 5.77 | ||||
| INAB | In8bio | 13.33 |
Complementary Tools for INmune Stock analysis
When running INmune Bio's price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |